Surgical Department, Sahlgrenska University Hospital
Gothenburg, Västra Götalandsregionen, 41345, Sweden
NCT Number: NCT03032224
The occurrence of dysphagia is a well-known early feature of esophageal cancer that may reduce caloric intake and thus cause weight loss. Sarcopenia is considered to be a consequence of such involuntary nutritional restriction. The prevalence of sarcopenia in patients with esophageal cancer before and after surgery is not well known and its possible consequences have been debated.
Aim: The aim of this study was to prospectively explore body composition and function in a cohort of patients with esophageal cancer before and after surgery with curative intent. In particular, to investigate the prevalence and development of sarcopenia and body composition as a consequence to surgery for esophageal cancer and the possible relation to morbidity, length of stay and quality of life (QoL).
Methods: In a cohort of 76 patients who had esophageal- or cardia-cancer and were planned for surgery with a curative intent, data on body-composition measured with bioimpedance, working capacity (cardiac stress test), grip strength and QoL (European Organisation for Research and Treatment of Cancer (EORTC) Quality of Life Questionnaires (QLQ)-C30 version 3.0) were prospectively collected. Data regarding dysphagia was derived from an esophagus related quality of life form (EORTC QLQ-OES18). Data on tumour stage and type, complications, length of stay and preoperative weight loss were collected from medical charts.
Looking for future studies?
Notify MeAll sexes
Observational
Gothenburg, Västra Götalandsregionen, 41345, Sweden
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: Three months
Body mass index (BMI) kg/m2
Time frame: Three months
Weight kg
Time frame: Three months
Fat free mass (FFM) kg;
Time frame: Three months
Fat mass (FM) kg;
Time frame: Three months
Lean tissue mass (LTM) kg;
Time frame: Three months
Total body water (TBW) l;
Time frame: Three months
Intra cellular water (ICW) l;
Time frame: Three months
Extra cellular water (ECW) l
Time frame: From surgery up to three months
Time frame: From surgery up to three months
Time frame: From surgery up to three months
Time frame: From surgery up to three months
Time frame: Length of survival after surgery
Vastra Gotaland Region
Other Gov
Analysis of Sarcopenia and Body Composition in Relation to Outcome in a Cohort of Patients With Esophageal Cancer or Cancer of the Gastroesophageal Junction Before and After Surgery With Curative Intent
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03102229
Cancer of Esophagus, Cancer of Lung
The Bronx, New York, United States
View Trial DetailsNCT03301493
Adenocarcinoma, Breast Diseases
Salzburg, State of Salzburg, Austria
View Trial DetailsNCT03133286
Adnexal Diseases, Anus Diseases
Compton, California, United States
View Trial DetailsNCT05088304
Atrophy, Cancer of Esophagus
View Trial Details